Published in Immunity on October 01, 1996
Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50
Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med (2002) 4.67
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med (2002) 4.32
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med (1997) 2.70
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sci U S A (1997) 2.53
Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17
2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med (2004) 1.88
Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med (2000) 1.69
A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med (1997) 1.59
Infection of dendritic cells by lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol (2003) 1.35
Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med (1999) 1.34
CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med (1997) 1.13
Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med (2001) 1.10
NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer (2015) 1.04
Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes. Clin Diagn Lab Immunol (2002) 1.02
Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun (2009) 1.01
Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity. Blood (2011) 0.99
Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J Immunol (2008) 0.98
Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immun (2001) 0.97
Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol (2001) 0.96
Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood (2011) 0.96
Natural killer cells as indispensable players and therapeutic targets in autoimmunity. Autoimmunity (2010) 0.86
CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection. Viral Immunol (2009) 0.85
Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours. Br J Cancer (1998) 0.83
Loss of cytotoxicity and gain of cytokine production in murine tumor-activated NK cells. PLoS One (2014) 0.77
Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance. Clin Exp Immunol (2003) 0.77
Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro. Clin Exp Immunol (1999) 0.76
Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. PLoS One (2014) 0.75
Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules. Med Microbiol Immunol (2005) 0.75
Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. Cancer Immun (2008) 0.75
Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. Front Immunol (2017) 0.75
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73
Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (1989) 7.11
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med (1985) 3.86
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med (2000) 3.26
Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci U S A (1992) 2.99
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci U S A (1991) 2.68
Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol (1997) 2.25
Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet (1983) 1.78
Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med (2000) 1.65
Targeting of human dendritic cells by autologous NK cells. J Immunol (1999) 1.62
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. Hum Immunol (2001) 1.57
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol (1985) 1.51
Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat Immunol (2000) 1.44
CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J Immunol (2000) 1.41
Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol (2000) 1.40
[Pneumothorax, atelectasis, and pleural effusion secondary to the placement of an enteral feeding tube]. Rev Clin Esp (1992) 1.38
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis (2000) 1.38
Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains. J Exp Med (1995) 1.38
Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J Exp Med (1988) 1.34
Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med (1999) 1.34
Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target. J Exp Med (1991) 1.33
Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol (1997) 1.31
Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis. J Immunol (2001) 1.30
Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype. Eur J Immunol (1990) 1.29
Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1992) 1.28
In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun (2001) 1.26
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol (2001) 1.24
Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer (2012) 1.22
IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol (2000) 1.22
A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol (2001) 1.17
A simple method for the construction of small format tissue arrays. J Clin Pathol (2003) 1.16
Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice. J Immunol (2000) 1.15
Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Proc Natl Acad Sci U S A (1994) 1.15
Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology (1992) 1.13
Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol (1999) 1.12
Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev (1997) 1.10
Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells. J Exp Med (1992) 1.10
TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity. Eur J Immunol (1996) 1.10
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol (2000) 1.09
cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol (2001) 1.07
Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. J Immunol (1999) 1.06
Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression. Opposing influences of T cell and natural killer mediated resistance? J Immunogenet (1987) 1.06
NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol (1999) 1.06
Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J Cancer (2000) 1.05
Resistance to H-2-restricted but not to allo-H2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant. J Immunol (1990) 1.03
TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur J Immunol (1993) 1.03
NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. J Immunol (1997) 1.01
Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur J Immunol (1991) 1.01
A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Cold Spring Harb Symp Quant Biol (1989) 1.01
New methods for assessing T-cell responses. Clin Diagn Lab Immunol (2000) 1.00
Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice. Eur J Immunol (1996) 1.00
Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J Immunol (2001) 1.00
HOXB homeobox gene expression in cervical carcinoma. Int J Gynecol Cancer (2006) 1.00
BK virus in liver transplant recipients: a prospective study. Transplant Proc (2009) 0.99
H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains. J Immunol (1994) 0.99
Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol (1998) 0.99
Triggering of murine NK cells by CD40 and CD86 (B7-2). J Immunol (1999) 0.98
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood (2000) 0.98
The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur J Immunol (1998) 0.98
Randomized controlled trial of aspiration needle versus automated biopsy device for transjugular liver biopsy. J Vasc Interv Radiol (2001) 0.95
The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy (2001) 0.95
Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol (1995) 0.95
Spread of measles virus through axonal pathways into limbic structures in the brain of TAP1 -/- mice. J Med Virol (1997) 0.94
TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J Immunol (1997) 0.93
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. J Immunol (1997) 0.93
Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. Int J Gynecol Cancer (2006) 0.92
Role of Qa-1(b)-binding receptors in the specificity of developing NK cells. Eur J Immunol (2000) 0.92
Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells. Proc Natl Acad Sci U S A (1997) 0.91
Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. J Viral Hepat (2006) 0.91
Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91
Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb. Eur J Immunol (1993) 0.90
Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther (2007) 0.90
Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation. J Immunol (1999) 0.88
Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl (2001) 0.87
Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. J Immunol (1994) 0.87
A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer. Int J Gynecol Cancer (2006) 0.87
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice. Leukemia (2006) 0.86
Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Clin Immunol (2000) 0.85
Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum. Parasite Immunol (1991) 0.85
Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Eur J Immunol (2001) 0.85
Processing of bacterial antigens for peptide presentation on MHC class I molecules. Immunol Rev (1999) 0.85
Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells. Eur J Immunol (1994) 0.85
Recurrence of Langerhans cell histiocytosis in the graft after liver transplantation in adults. Transplant Proc (2002) 0.84
IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells. Eur J Immunol (2001) 0.84
Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice. J Neurovirol (2001) 0.84
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity. Vaccine (1992) 0.84
Effect of IFN-gamma treatment and in vivo passage of murine tumor cell lines on their sensitivity to lymphokine-activated killer (LAK) cell lysis in vitro; association with H-2 expression on the target cells. Int J Cancer (1989) 0.84
NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma. Int J Cancer (1989) 0.84
Control of the autoimmune response by type 2 nitric oxide synthase. J Immunol (2001) 0.83
Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur J Immunol (1995) 0.83
Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence. Transpl Infect Dis (2009) 0.83
Pulmonary complications following orthotopic liver transplant. Transpl Int (1998) 0.83
P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice. J Neurosci Res (2000) 0.83
A missense point mutation (Leu13Arg) of the Norrie disease gene in a large Cuban kindred with Norrie disease. Hum Mol Genet (1994) 0.83